ALLIANCEBERNSTEIN L.P. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2022$174,000
-23.7%
54,600
+0.2%
0.00%
Q4 2021$228,000
-48.5%
54,5000.0%0.00%
Q3 2021$443,000
+7.8%
54,5000.0%0.00%
Q2 2021$411,000
-9.5%
54,500
+4.2%
0.00%
Q1 2021$454,000
+8.9%
52,3000.0%0.00%
Q4 2020$417,0000.0%52,3000.0%0.00%
Q3 2020$417,000
-19.5%
52,3000.0%0.00%
Q2 2020$518,000
+51.5%
52,300
+18.3%
0.00%
Q1 2020$342,000
+302.4%
44,200
+100.9%
0.00%
Q4 2019$85,000
-23.4%
22,0000.0%0.00%
Q3 2019$111,000
-23.4%
22,0000.0%0.00%
Q2 2019$145,000
-3.3%
22,000
+11.1%
0.00%
Q1 2019$150,000
+66.7%
19,800
+78.4%
0.00%
Q4 2018$90,00011,1000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 249,430$2,015,0001.24%
Manatuck Hill Partners, LLC 194,100$1,568,0000.81%
Skylands Capital, LLC 495,850$4,006,0000.66%
EAM Global Investors LLC 78,027$630,0000.34%
EAM Investors, LLC 107,531$869,0000.24%
Granahan Investment Management 278,170$2,248,0000.16%
Wealthcare Advisory Partners LLC 62,079$502,0000.10%
Avenir Corp 76,390$617,0000.08%
Crow Point Partners, LLC 48,576$380,0000.07%
Kalos Management, Inc. 14,700$120,0000.06%
View complete list of CYTOSORBENTS CORP shareholders